View in EDS

Using RNA-seq for detecting MRD in multiple myeloma: high sensitivity and prognostic value.

Saved in:
Bibliographic Details
Title: Using RNA-seq for detecting MRD in multiple myeloma: high sensitivity and prognostic value.
Authors: Ren Y; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Liu M; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China., Fang J; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China., Wang L; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Xue Y; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Zhao W; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Liu J; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Yu L; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Jin Y; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Chen L; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Tian Y; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Gao X; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Zhang X; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Han B; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Yao D; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Song Y; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Chen X; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China., Wang F; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China., Ma X; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China., Liu H; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China. starliu@pku.edu.cn.; Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China. starliu@pku.edu.cn.; Division of Pathology and Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China. starliu@pku.edu.cn.; Department of Oncology, Capital Medical University, Beijing, China. starliu@pku.edu.cn., Wang W; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China. weiwang0_0@163.com.
Source: Cancer gene therapy [Cancer Gene Ther] 2026 Jan; Vol. 33 (1), pp. 65-75. Date of Electronic Publication: 2025 Oct 24.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5500 (Electronic) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41136752
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Using RNA-seq for detecting MRD in multiple myeloma: high sensitivity and prognostic value.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ren+Y%22">Ren Y</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Liu+M%22">Liu M</searchLink>; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Fang+J%22">Fang J</searchLink>; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Xue+Y%22">Xue Y</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Zhao+W%22">Zhao W</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Yu+L%22">Yu L</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Jin+Y%22">Jin Y</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Tian+Y%22">Tian Y</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Gao+X%22">Gao X</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Han+B%22">Han B</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Yao+D%22">Yao D</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Song+Y%22">Song Y</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Wang+F%22">Wang F</searchLink>; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Ma+X%22">Ma X</searchLink>; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China.<br /><searchLink fieldCode="AU" term="%22Liu+H%22">Liu H</searchLink>; Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, Heilongjiang Province, China. starliu@pku.edu.cn.; Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China. starliu@pku.edu.cn.; Division of Pathology and Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China. starliu@pku.edu.cn.; Department of Oncology, Capital Medical University, Beijing, China. starliu@pku.edu.cn.<br /><searchLink fieldCode="AU" term="%22Wang+W%22">Wang W</searchLink>; Department of Hematopathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China. weiwang0_0@163.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229432230%22">Cancer gene therapy</searchLink> [Cancer Gene Ther] 2026 Jan; Vol. 33 (1), pp. 65-75. <i>Date of Electronic Publication: </i>2025 Oct 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9432230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5500 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209291903%22">09291903 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Gene Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41136752
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41417-025-00973-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 65
    Titles:
      – TitleFull: Using RNA-seq for detecting MRD in multiple myeloma: high sensitivity and prognostic value.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ren Y
      – PersonEntity:
          Name:
            NameFull: Liu M
      – PersonEntity:
          Name:
            NameFull: Fang J
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Xue Y
      – PersonEntity:
          Name:
            NameFull: Zhao W
      – PersonEntity:
          Name:
            NameFull: Liu J
      – PersonEntity:
          Name:
            NameFull: Yu L
      – PersonEntity:
          Name:
            NameFull: Jin Y
      – PersonEntity:
          Name:
            NameFull: Chen L
      – PersonEntity:
          Name:
            NameFull: Tian Y
      – PersonEntity:
          Name:
            NameFull: Gao X
      – PersonEntity:
          Name:
            NameFull: Zhang X
      – PersonEntity:
          Name:
            NameFull: Han B
      – PersonEntity:
          Name:
            NameFull: Yao D
      – PersonEntity:
          Name:
            NameFull: Song Y
      – PersonEntity:
          Name:
            NameFull: Chen X
      – PersonEntity:
          Name:
            NameFull: Wang F
      – PersonEntity:
          Name:
            NameFull: Ma X
      – PersonEntity:
          Name:
            NameFull: Liu H
      – PersonEntity:
          Name:
            NameFull: Wang W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5500
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer gene therapy
              Type: main
ResultId 1